Product information
From Health Canada
Note - The product information found within this database originates from organizations not subject to the Official Languages Act and is available in the language in which it was written and submitted to Health Canada.
Note - The market status of a product is now available in the LNHPD and identifies if a product is "marketed" or "not marketed" in Canada. Product licence holders may voluntarily provide the Natural and Non-Prescription Health Products Directorate (NNHPD) with information about whether their product is currently available to Canadian consumers. Where no information has been provided, the default status is "not marketed". The "current status" field remains unaffected and will continue to indicate the status of the product licence (i.e., active, discontinued, stop sale, cancelled, or suspended). Note that where a licence has been suspended, cancelled or under stop sale, the product cannot be legally sold in Canada.
Product licence holders - if you wish to update a product's market status, you are invited to complete the Natural Health Products Market Notification Web Form. As with all other notifications, there is no current service standard. The NNHPD will process the market status update as soon as feasible, based on its available resources. As a reminder, market notification is voluntary; therefore, a licence holder is not required to wait for the LNHPD to be updated before a licensed product is sold in Canada. As such, products that are identified in the LNHPD as "not marketed" may still be sold in Canada.
- Natural Product Number (NPN):
- 80097012
- Market status:
- Marketed
- Licence Status:
- Active
- Brand name(s):
-
Saffron
;
Ado Zen ;
Saffron Zen ;
Safran Zen ;
Teen Zen - Licence holder:
- New Roots Herbal Inc.
- Dosage Form:
- Capsule
- Recommended route of administration:
-
Oral
Sub population (Sub Pop.) | Quantity (Qty) | Frequency (Freq.) | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Sub Pop. | Age | Min. | Max. | UoM Footnote1 Age | Qty | Min. | Max. | UoM Qty | Freq. | Min. | Max. | UoM Freq. |
Adolescents | 12 | 17 | year(s) | 1.0 | capsule | 2 | day | |||||
Adults | 18 | Years | 1.0 | capsule | 2 | day | ||||||
- Recommended use or purpose:
- Helps to support mood balance. Helps to support mood balance in adolescents and youths 12 years and over. Affron Helps to relieve restlessness and/or nervousness (calmative). Supports positive effects on symptoms of perceived stress such as, fatigue, weariness, and irritability. Helps to reduce the symptoms of perceived stress, such as fatigue, weariness, and irritability. Helps to improve restorative sleep, in individuals experiencing sleeplessness. Helps improve sleep quality in individuals experiencing sleeplessness. Helps to support/maintain (healthy) mood balance. Clinically proven to support/maintain (healthy) mood balance. Affron is clinically shown to relieve restlessness and/or nervousness (calmative). Clinically shown to support positive effects on symptoms of perceived stress such as, fatigue, weariness, and irritability. Clinically shown to reduce the symptoms of perceived stress, such as fatigue, weariness, and irritability. Clinically shown to improve restorative sleep, in individuals experiencing sleeplessness. Supports the management of symptoms associated with perimenopause. Helps improve sleep quality. Clinically proven to help improve sleep quality. Clinically proven to help improve sleep quality in 4 weeks. Clinically proven to improve sleep quality in individuals experiencing sleeplessness. May help to support healthy mood balance during perimenopause. Helps to support healthy mood balance during perimenopause. Clinically shown to help relieve symptoms associated with perimenopause. Helps to support mood balance after awakening. Helps to support healthy mood balance after awakening.
- Risk Information:
- Cautions and Warnings
- If symptoms persist or worsen, consult a health care practitioner. If you suffer from any psychological disorder and/or condition such as frequent anxiety or depression, consult a healthcare practitioner prior to use. Consult a healthcare practitioner prior to use if you are taking antidepressants. Consult a health care practitioner if sleeplessness persists continuously for more than 4 weeks (chronic insomnia).
- Contra-Indications
- Do not use if you are taking blood thinners/anticoagulants or have a bleeding disorder. Do not use if you are pregnant or breastfeeding.
Medicinal ingredients | Quantity (Qty) | Extract | Potency |
---|---|---|---|
Crocus sativus |
14.0 mg
|
3
:
1
DHE: 42 mg Dry |
0.03
%
2,6,6-Trimethylcyclohexa-1,3-diene-1-carbaldehyde 3.48 % Crocin |
- List of non-medicinal ingredients:
-
- Carbohydrate gum
- Magnesium stearate
- Microcrystalline cellulose
- Purified water
- Silicon dioxide
- Date of licensing:
- 2020-02-06
- Revised date of licence:
- 2024-10-03
Application information
Related information
Contact us
For technical support or if you have general questions concerning the content of this database, please contact the Natural Health Products Directorate (NHPD).